Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) (ASPIRE)

This study has been terminated.
Information provided by (Responsible Party):
Aeris Therapeutics Identifier:
First received: October 6, 2011
Last updated: November 13, 2013
Last verified: November 2013